BioSpace News Archive

Business

GSK Abandons Cell Therapy Collaboration with Lyell

GSK terminated its cell therapy pact with Lyell Immunopharma. It’s opting to advance its own programs without use of Lyell’s T-cell modulating technologies that were at the center of the partnership.

October 25, 2022
·
2 min read
·
Alex Keown
Canada Latent Tuberculosis Infection Detection Market Size, Report 2022 to 2030

The Canada latent tuberculosis infection detection market size was recorded at USD 27.4 million in 2021 and it is expected to surpass around USD 47.31 million by 2030, poised to grow at a CAGR of 6.26% from 2022 to 2030.

October 25, 2022
·
6 min read
Cloning And Mutagenesis Market Size, Growth, Trends, Report 2022-2030

Latest Research Report on “Cloning and Mutagenesis Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030”.

October 25, 2022
·
4 min read
Business

Silk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2022 after market close on Tuesday, November 8th, 2022.

October 25, 2022
·
1 min read
Business

Nektar to Announce Financial Results for the Third Quarter 2022 on Thursday, November 3, 2022, After Close of U.S.-Based Financial Markets

Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2022 on Thursday, November 3, 2022, after the close of U.S.-based financial markets.

October 25, 2022
·
1 min read
Business

Bristol Myers Squibb Reports Third Quarter Financial Results for 2022

Bristol Myers Squibb (NYSE:BMY) today reports results for the third quarter of 2022, which reflect strong in-line and new product portfolio growth.

October 25, 2022
·
39 min read
HLA Typing Market Size, Trends, Share, Growth | Report 2022-2030

According to Vision Research Reports, the HLA typing market was surpassed at USD 1.3 billion in 2021 and is expected to hit around USD 2.11 billion by 2030, growing at a CAGR of 5.53% from 2022 to 2030.

October 25, 2022
·
6 min read
Business

STERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022

STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 second quarter financial results at 10:00 a.m. ET on November 10, 2022.

October 25, 2022
·
7 min read
Business

Mirati Therapeutics to Report Third Quarter 2022 Financial Results and Recent Corporate Updates

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will announce financial results for the third quarter of 2022 along with recent corporate updates on November 8, 2022.

October 25, 2022
·
3 min read
Immunofluorescence Assay Market Size, Share, Report 2022-2030

According to Vision Research Reports, the global immunofluorescence assay market size is expected to surpass around USD 4.61 billion by 2030, poised to grow at a CAGR of 6.8% from 2022 to 2030.

October 25, 2022
·
7 min read